首页 > 最新文献

Journal of immunology and regenerative medicine最新文献

英文 中文
Osteogenic differentiation driven by osteoclasts and macrophages 破骨细胞和巨噬细胞驱动的成骨分化
Pub Date : 2021-05-01 DOI: 10.1016/j.regen.2021.100044
Talita Stessuk , Johanna Husch , Inge AT. Hermens , Sandra Hofmann , Jeroen JJP. van den Beucken

Introduction

Osteoclasts are bone-resorbing cells closely related to bone turnover, whereas different macrophage subtypes contribute to bone fracture healing. As osteoclasts and macrophages share the same hematopoietic origin, the difference between both cell types on osteoblast coupling, crosstalk extent and consequent bone formation remains poorly understood. This study compares the potential of primary cells that are routinely considered as osteoclast and macrophage cultures on their ability to support osteogenic differentiation of human mesenchymal stromal cells (hMSCs).

Methods

Human Peripheral Blood Mononuclear Cells (hPBMCs) were used to obtain macrophage or osteoclast cultures using appropriate stimulatory factors. With different seeding densities of hPBMCs, conditioned media from macrophage or osteoclast cultures were harvested for comparative evaluation of effects thereof on the osteogenic differentiation of hMSCs. Specific cytological staining was used to qualitatively evaluate macrophage and osteoclast cultures. Additionally, quantitative data on hMSC proliferation, osteogenic differentiation and mineralization were obtained via biochemical assays.

Results

Conditioned medium from osteoclast cultures obtained via low hPBMCs seeding densities, but not from high hPBMCs seeding densities or macrophages, stimulated hMSC osteogenic differentiation and mineralization. Upon cellular crosstalk, both pre-differentiated osteoclasts and non-polarized macrophages equally supported early hMSC osteogenic differentiation and mineralization, as confirmed by increased alkaline phosphatase levels within 7 days and increased calcium content within 14 days in comparison with undifferentiated controls. Initial hPBMCs seeding density strongly influences osteoclastogenesis and the paracrine effect of the resultant osteoclast population on the osteogenic differentiation of hMSCs. In addition, only in indirect coculture, macrophages provide similar stimulatory effects as pre-differentiated osteoclasts on the osteogenic differentiation of MSCs and mineralization.

Conclusion

Our results demonstrate stimulatory effects of osteoclast conditioned medium on hMSC osteogenic differentiation, depending on initial hPBMC seeding density. In addition, we show that osteoclast and macrophage cultures contain pools of polarized macrophages, which may be involved in the osteogenic effects. Our data provide insight into bone tissue engineering approaches by using multicellular interactions related to bone remodeling and healing for the in vitro modulation of osteogenic differentiation.

破骨细胞是与骨转换密切相关的骨吸收细胞,而不同亚型的巨噬细胞有助于骨折愈合。由于破骨细胞和巨噬细胞具有相同的造血起源,两种细胞在成骨细胞偶联、串扰程度和随后的骨形成方面的差异尚不清楚。本研究比较了通常被认为是破骨细胞和巨噬细胞培养的原代细胞在支持人间充质基质细胞(hMSCs)成骨分化方面的潜力。方法采用人外周血单核细胞(hPBMCs),在适当的刺激因子作用下获得巨噬细胞或破骨细胞培养物。在不同的hpbmc播种密度下,从巨噬细胞或破骨细胞培养中获取条件培养基,比较评估其对hpbscs成骨分化的影响。特异性细胞学染色定性评价巨噬细胞和破骨细胞培养。此外,通过生化分析获得hMSC增殖、成骨分化和矿化的定量数据。结果低hPBMCs播种密度而非高hPBMCs播种密度或巨噬细胞培养的破骨细胞培养基刺激hMSC成骨分化和矿化。在细胞相互作用下,与未分化的对照组相比,预分化破骨细胞和非极化巨噬细胞同样支持早期hMSC成骨分化和矿化,在7天内碱性磷酸酶水平升高,14天内钙含量增加。初始hPBMCs播种密度强烈影响破骨细胞的发生以及由此产生的破骨细胞群对hMSCs成骨分化的旁分泌作用。此外,只有在间接共培养中,巨噬细胞对MSCs的成骨分化和矿化的刺激作用与预分化破骨细胞相似。结论破骨细胞条件培养基对人骨髓间充质干细胞成骨分化的促进作用取决于初始人骨髓间充质干细胞的播种密度。此外,我们发现破骨细胞和巨噬细胞培养物中含有极化巨噬细胞池,这可能参与成骨作用。我们的数据通过使用与骨重塑和愈合相关的多细胞相互作用来体外调节成骨分化,为骨组织工程方法提供了见解。
{"title":"Osteogenic differentiation driven by osteoclasts and macrophages","authors":"Talita Stessuk ,&nbsp;Johanna Husch ,&nbsp;Inge AT. Hermens ,&nbsp;Sandra Hofmann ,&nbsp;Jeroen JJP. van den Beucken","doi":"10.1016/j.regen.2021.100044","DOIUrl":"10.1016/j.regen.2021.100044","url":null,"abstract":"<div><h3>Introduction</h3><p>Osteoclasts are bone-resorbing cells closely related to bone turnover, whereas different macrophage subtypes contribute to bone fracture healing. As osteoclasts and macrophages share the same hematopoietic origin, the difference between both cell types on osteoblast coupling, crosstalk extent and consequent bone formation remains poorly understood. This study compares the potential of primary cells that are routinely considered as osteoclast and macrophage cultures on their ability to support osteogenic differentiation of human mesenchymal stromal cells (hMSCs).</p></div><div><h3>Methods</h3><p>Human Peripheral Blood Mononuclear Cells (hPBMCs) were used to obtain macrophage or osteoclast cultures using appropriate stimulatory factors. With different seeding densities of hPBMCs, conditioned media from macrophage or osteoclast cultures were harvested for comparative evaluation of effects thereof on the osteogenic differentiation of hMSCs. Specific cytological staining was used to qualitatively evaluate macrophage and osteoclast cultures. Additionally, quantitative data on hMSC proliferation, osteogenic differentiation and mineralization were obtained via biochemical assays.</p></div><div><h3>Results</h3><p>Conditioned medium from osteoclast cultures obtained via low hPBMCs seeding densities, but not from high hPBMCs seeding densities or macrophages, stimulated hMSC osteogenic differentiation and mineralization. Upon cellular crosstalk, both pre-differentiated osteoclasts and non-polarized macrophages equally supported early hMSC osteogenic differentiation and mineralization, as confirmed by increased alkaline phosphatase levels within 7 days and increased calcium content within 14 days in comparison with undifferentiated controls. Initial hPBMCs seeding density strongly influences osteoclastogenesis and the paracrine effect of the resultant osteoclast population on the osteogenic differentiation of hMSCs. In addition, only in indirect coculture, macrophages provide similar stimulatory effects as pre-differentiated osteoclasts on the osteogenic differentiation of MSCs and mineralization.</p></div><div><h3>Conclusion</h3><p>Our results demonstrate stimulatory effects of osteoclast conditioned medium on hMSC osteogenic differentiation, depending on initial hPBMC seeding density. In addition, we show that osteoclast and macrophage cultures contain pools of polarized macrophages, which may be involved in the osteogenic effects. Our data provide insight into bone tissue engineering approaches by using multicellular interactions related to bone remodeling and healing for the in vitro modulation of osteogenic differentiation.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"12 ","pages":"Article 100044"},"PeriodicalIF":0.0,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2021.100044","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84004313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Macrophage retrieval from 3D biomaterials: A detailed comparison of common dissociation methods 从3D生物材料中提取巨噬细胞:常见解离方法的详细比较
Pub Date : 2021-02-01 DOI: 10.1016/j.regen.2020.100035
Nora Feuerer , Johannes Morschl , Ruben Daum , Martin Weiss , Svenja Hinderer , Katja Schenke-Layland , Christopher Shipp

Introduction

The immune system is widely recognized as a crucial determinant in implant biocompatibility and tissue integration. In order to assess macrophage response to biomaterials, commonly used analysis techniques require the removal of cells from the material. This process inherently has a negative impact on the cells, but few studies have comprehensively compared different dissociation methods in terms of impact on cell yield, viability, phenotype and function.

Methods

Cell scraping, EDTA at 4 °C, EDTA at 37 °C, trypsin, Accutase and the PromoCell macrophage detachment solution were compared in terms of cell yield and viability. The effect of Accutase on cell surface antigen conservancy and cell functionality was investigated. Lastly, effect of Accutase detachment of macrophages from electrospun biomaterials was analyzed.

Results

The efficiency of common cell detachment protocols for human monocyte-derived macrophages (MDMs) varies significantly between enzymatic and non-enzymatic approaches. In terms of surface marker detection, we showed that enzymatic detachment not only selectively cleaves the M2 markers CD206 and CD163, but we also identified that this effect is variable across donors. Furthermore, we observed that the process of cell detachment impairs macrophage endocytic ability. Lastly, we tested the efficiency of enzymatic cell detachment on electrospun 3D matrices designed for tissue engineering.

Conclusion

Our results provide a thorough understanding of the advantages and disadvantages of commonly used cell dissociation methods and have important implications for studies investigating the macrophage response to biomaterials.

免疫系统被广泛认为是种植体生物相容性和组织整合的关键决定因素。为了评估巨噬细胞对生物材料的反应,常用的分析技术需要从材料中去除细胞。这一过程本身对细胞有负面影响,但很少有研究全面比较不同解离方法对细胞产量、活力、表型和功能的影响。方法比较细胞刮片、4℃EDTA、37℃EDTA、胰蛋白酶、Accutase和PromoCell巨噬细胞分离液的细胞产量和活力。研究了精化酶对细胞表面抗原保护和细胞功能的影响。最后,分析了电纺丝生物材料巨噬细胞的Accutase分离效果。结果酶法和非酶法分离人单核细胞源性巨噬细胞(MDMs)的效率差异显著。在表面标记检测方面,我们发现酶分离不仅选择性地切割M2标记CD206和CD163,而且我们还发现这种效果在不同的供体中是可变的。此外,我们观察到细胞脱离的过程损害了巨噬细胞的内吞能力。最后,我们测试了用于组织工程的静电纺丝三维基质上酶解细胞的效率。结论我们的研究结果全面了解了常用的细胞分离方法的优缺点,对研究巨噬细胞对生物材料的反应具有重要意义。
{"title":"Macrophage retrieval from 3D biomaterials: A detailed comparison of common dissociation methods","authors":"Nora Feuerer ,&nbsp;Johannes Morschl ,&nbsp;Ruben Daum ,&nbsp;Martin Weiss ,&nbsp;Svenja Hinderer ,&nbsp;Katja Schenke-Layland ,&nbsp;Christopher Shipp","doi":"10.1016/j.regen.2020.100035","DOIUrl":"10.1016/j.regen.2020.100035","url":null,"abstract":"<div><h3>Introduction</h3><p>The immune system is widely recognized as a crucial determinant in implant biocompatibility and tissue integration. In order to assess macrophage response to biomaterials, commonly used analysis techniques require the removal of cells from the material. This process inherently has a negative impact on the cells, but few studies have comprehensively compared different dissociation methods in terms of impact on cell yield, viability, phenotype and function.</p></div><div><h3>Methods</h3><p>Cell scraping, EDTA at 4 °C, EDTA at 37 °C, trypsin, Accutase and the PromoCell macrophage detachment solution were compared in terms of cell yield and viability. The effect of Accutase on cell surface antigen conservancy and cell functionality was investigated. Lastly, effect of Accutase detachment of macrophages from electrospun biomaterials was analyzed.</p></div><div><h3>Results</h3><p>The efficiency of common cell detachment protocols for human monocyte-derived macrophages (MDMs) varies significantly between enzymatic and non-enzymatic approaches. In terms of surface marker detection, we showed that enzymatic detachment not only selectively cleaves the M2 markers CD206 and CD163, but we also identified that this effect is variable across donors. Furthermore, we observed that the process of cell detachment impairs macrophage endocytic ability. Lastly, we tested the efficiency of enzymatic cell detachment on electrospun 3D matrices designed for tissue engineering.</p></div><div><h3>Conclusion</h3><p>Our results provide a thorough understanding of the advantages and disadvantages of commonly used cell dissociation methods and have important implications for studies investigating the macrophage response to biomaterials.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"11 ","pages":"Article 100035"},"PeriodicalIF":0.0,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2020.100035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85018590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Manufacturing of natural killer cells for treating solid malignancies 制造用于治疗实体恶性肿瘤的自然杀伤细胞
Pub Date : 2020-12-01 DOI: 10.1016/j.regen.2020.100031
Madison N. Temples, Blanka Sharma

Objectives

Natural killer (NK) cells are an attractive and potent tool for cancer immunotherapy, however, ex vivo expansion of NK cells is required to achieve therapeutic cell dosages. As such, this review will discuss recent NK cell manufacturing methods applied in clinical trials for expanded NK cells for the treatment of solid tumors, as well as investigational NK cell manufacturing protocols. Given the unique challenges posed by the solid tumor microenvironment, the main objective of this review is to highlight key biological mechanisms associated with tumor homing and infiltration of NK cells and how manufacturing methods impact these functions.

Key findings

For efficient adoptive NK cell therapy for the treatment of solid malignancies, NK cells need to extravasate from the blood stream, migrate through the tumor extracellular matrix, lyse cancer cells, activate other immune cells, and persist in the blood stream. The NK cell manufacturing process is complex, with each parameter influencing the expansion rate, and final NK cell number, purity, phonotype, and cytotoxicity. Many investigational and clinical NK cell manufacturing protocols generate high numbers of NK cells with greater cytotoxicity than freshly isolated NK cells. The expression of factors related to homing and migration in NK cells after ex vivo expansion is largely overlooked, but the few studies which have explored this indicate manufacturing processes can affect these critical mechanisms.

Conclusion

The current manufacturing protocols can generate high numbers of NK cells with increased cytotoxic functions, however understanding the effect of expansion on factors related to NK cell homing and migration is also important for treating solid malignancies. Furthermore, to progress the field of expanded NK cells for the treatment of solid tumors, improving “off-the-shelf” NK cell therapies and standardizing the manufacturing protocols and release criteria should be prioritized.

自然杀伤细胞(NK)是癌症免疫治疗的一种有吸引力且有效的工具,然而,NK细胞的体外扩增需要达到治疗细胞剂量。因此,本综述将讨论最近应用于扩增NK细胞治疗实体瘤的临床试验中的NK细胞制造方法,以及研究性NK细胞制造方案。鉴于实体肿瘤微环境带来的独特挑战,本综述的主要目的是强调与肿瘤归巢和NK细胞浸润相关的关键生物学机制,以及制造方法如何影响这些功能。为了有效地过继NK细胞治疗实体恶性肿瘤,NK细胞需要从血流中渗出,通过肿瘤细胞外基质迁移,溶解癌细胞,激活其他免疫细胞,并在血流中持续存在。NK细胞的制造过程是复杂的,每个参数都会影响扩增率,以及最终的NK细胞数量、纯度、声型和细胞毒性。许多研究和临床NK细胞制造方案产生大量的NK细胞,比新分离的NK细胞具有更大的细胞毒性。NK细胞在体外扩增后,与归巢和迁移相关的因子的表达在很大程度上被忽视了,但少数探索这一点的研究表明,制造过程可以影响这些关键机制。结论目前的制造方案可以产生大量具有细胞毒性功能的NK细胞,但是了解NK细胞扩增对NK细胞归巢和迁移相关因子的影响对于治疗实体恶性肿瘤也很重要。此外,为了推进扩增NK细胞在实体瘤治疗领域的发展,应优先改进“现成”NK细胞疗法,规范制造方案和释放标准。
{"title":"Manufacturing of natural killer cells for treating solid malignancies","authors":"Madison N. Temples,&nbsp;Blanka Sharma","doi":"10.1016/j.regen.2020.100031","DOIUrl":"10.1016/j.regen.2020.100031","url":null,"abstract":"<div><h3>Objectives</h3><p><span>Natural killer (NK) cells are an attractive and potent tool for cancer immunotherapy, however, </span><span><em>ex vivo</em></span><span> expansion of NK cells is required to achieve therapeutic cell dosages. As such, this review will discuss recent NK cell manufacturing methods applied in clinical trials<span><span> for expanded NK cells for the treatment of </span>solid tumors<span><span>, as well as investigational NK cell manufacturing protocols. Given the unique challenges posed by the solid tumor microenvironment, the main objective of this review is to highlight key biological mechanisms associated with tumor homing and </span>infiltration of NK cells and how manufacturing methods impact these functions.</span></span></span></p></div><div><h3>Key findings</h3><p><span><span>For efficient adoptive NK cell therapy for the treatment of solid malignancies<span>, NK cells need to extravasate from the blood stream, migrate through the tumor extracellular matrix, lyse </span></span>cancer cells<span>, activate other immune cells<span>, and persist in the blood stream. The NK cell manufacturing process is complex, with each parameter influencing the expansion rate, and final NK cell number, purity, phonotype, and cytotoxicity. Many investigational and clinical NK cell manufacturing protocols generate high numbers of NK cells with greater cytotoxicity than freshly isolated NK cells. The expression of factors related to homing and migration in NK cells after </span></span></span><em>ex vivo</em> expansion is largely overlooked, but the few studies which have explored this indicate manufacturing processes can affect these critical mechanisms.</p></div><div><h3>Conclusion</h3><p>The current manufacturing protocols can generate high numbers of NK cells with increased cytotoxic functions, however understanding the effect of expansion on factors related to NK cell homing and migration is also important for treating solid malignancies. Furthermore, to progress the field of expanded NK cells for the treatment of solid tumors, improving “off-the-shelf” NK cell therapies and standardizing the manufacturing protocols and release criteria should be prioritized.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"10 ","pages":"Article 100031"},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2020.100031","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85457477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microfluidic chip for label-free removal of teratoma-forming cells from therapeutic human stem cells 用于从治疗性人类干细胞中无标记去除畸胎瘤形成细胞的微流控芯片
Pub Date : 2020-12-01 DOI: 10.1016/j.regen.2020.100030
Kyle Wellmerling , Christian Lehmann , Ankur Singh , Brian J. Kirby

Teratoma formation remains a safety concern in therapeutic cells derived from human-induced pluripotent stem cells (hiPSCs). Residual Teratoma forming cells are present in small numbers in differentiated hiPSC cultures and yet are of significant roadblock to the manufacturing and clinical translation of stem cell therapies. Rare cells are often difficult to remove with standard flow cytometry or magnetic bead sorting techniques. Here, we first characterized time-dependent expression of a teratoma marker, stage-specific embryonic antigen (SSEA)-5, which binds the H type-1 glycan during neural differentiation of hiPSCs. The fraction of cells SSEA-5+ remained high at 97% on day 3, dropped to 70% on day 4, 40% by day 6, and down to 1% on day 12 of differentiation, indicating successful differentiation. We engineered a microfluidic geometrically enhanced differential immunocapture (GEDI) technology to remove SSEA-5+ rare cells from hiPSC-derived neural progenitor cells (hiPSC-NPCs). The GEDI chip removed more than 95% of teratoma-forming cells and presents a facile tool to potentially functionalize with multiple antibodies and robustly enhance hiPSC-derived cell population safety prior to therapeutic transplantation. The approach is potentially amenable to generate a wide variety of high-quality therapeutic cells and can be integrated within the pipeline of cell manufacturing to improve patient safety and reduce the cost of manufacturing through early removal of undesirable cell types.

畸胎瘤形成仍然是人类诱导多能干细胞(hiPSCs)衍生的治疗细胞的安全性问题。在分化的hiPSC培养物中,残留的畸胎瘤形成细胞数量很少,但这对干细胞疗法的制造和临床翻译来说是一个重大障碍。稀有细胞通常难以用标准流式细胞术或磁珠分选技术去除。在这里,我们首先表征了畸胎瘤标志物阶段特异性胚胎抗原(SSEA)-5的时间依赖性表达,该抗原在hipsc的神经分化过程中与H型1聚糖结合。SSEA-5+细胞的比例在分化第3天保持在97%的高位,第4天降至70%,第6天降至40%,第12天降至1%,表明分化成功。我们设计了一种微流体几何增强差分免疫捕获(GEDI)技术,从hipsc衍生的神经祖细胞(hipsc - npc)中去除SSEA-5+稀有细胞。GEDI芯片清除了超过95%的畸胎瘤形成细胞,并提供了一种简便的工具,可以与多种抗体进行潜在的功能化,并在治疗性移植之前显著提高hipsc来源的细胞群的安全性。这种方法有可能产生各种各样的高质量治疗细胞,并且可以整合到细胞制造的管道中,通过早期去除不需要的细胞类型来提高患者的安全性并降低制造成本。
{"title":"Microfluidic chip for label-free removal of teratoma-forming cells from therapeutic human stem cells","authors":"Kyle Wellmerling ,&nbsp;Christian Lehmann ,&nbsp;Ankur Singh ,&nbsp;Brian J. Kirby","doi":"10.1016/j.regen.2020.100030","DOIUrl":"10.1016/j.regen.2020.100030","url":null,"abstract":"<div><p>Teratoma<span><span> formation remains a safety concern in therapeutic cells derived from human-induced pluripotent stem cells (hiPSCs). Residual Teratoma forming cells are present in small numbers in differentiated hiPSC cultures and yet are of significant roadblock to the manufacturing and clinical translation of stem cell therapies. Rare cells are often difficult to remove with standard flow cytometry or magnetic bead sorting techniques. Here, we first characterized time-dependent expression of a teratoma marker, stage-specific embryonic antigen (SSEA)-5, which binds the H type-1 </span>glycan<span> during neural differentiation of hiPSCs. The fraction of cells SSEA-5+ remained high at 97% on day 3, dropped to 70% on day 4, 40% by day 6, and down to 1% on day 12 of differentiation, indicating successful differentiation. We engineered a microfluidic geometrically enhanced differential immunocapture (GEDI) technology to remove SSEA-5+ rare cells from hiPSC-derived neural progenitor cells (hiPSC-NPCs). The GEDI chip removed more than 95% of teratoma-forming cells and presents a facile tool to potentially functionalize with multiple antibodies and robustly enhance hiPSC-derived cell population safety prior to therapeutic transplantation. The approach is potentially amenable to generate a wide variety of high-quality therapeutic cells and can be integrated within the pipeline of cell manufacturing<span> to improve patient safety and reduce the cost of manufacturing through early removal of undesirable cell types.</span></span></span></p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"10 ","pages":"Article 100030"},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2020.100030","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84112848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Cardiac fibroblast derived matrix-educated macrophages express VEGF and IL-6, and recruit mesenchymal stromal cells 心肌成纤维细胞衍生的基质培养巨噬细胞表达VEGF和IL-6,并招募间充质基质细胞
Pub Date : 2020-12-01 DOI: 10.1016/j.regen.2020.100033
Sushmita Roy , Keith Spinali , Eric G. Schmuck , John A. Kink , Peiman Hematti , Amish N. Raval

The polarization of monocytes into macrophages that possess anti-inflammatory and pro-angiogenic properties could provide a novel therapeutic strategy for patients who are at a high risk for developing heart failure following myocardial infarction (MI). Here in, we describe a novel method of “educating” monocytes into a distinct population of macrophages that exhibit anti-inflammatory and pro-angiogenic features through a 3-day culture on fibronectin-rich cardiac matrix (CX) manufactured using cultured human cardiac fibroblasts. Our data suggest that CX can educate monocytes into a unique macrophage population termed CX educated macrophages (CXMq) that secrete high levels of VEGF and IL-6. In vitro, CXMq also demonstrate the ability to recruit mesenchymal stromal cells (MSC) with known anti-inflammatory properties. Selective inhibition of fibronectin binding to αVβ3 surface integrins on CXMq prevented MSC recruitment. This suggests that insoluble fibronectin within CX is, at least in part, responsible for CXMq conversion.

单核细胞分化为巨噬细胞,具有抗炎和促血管生成的特性,可以为心肌梗死(MI)后心力衰竭高风险患者提供一种新的治疗策略。在本文中,我们描述了一种将单核细胞“培养”成巨噬细胞的新方法,通过在富含纤维连接蛋白的心脏基质(CX)上培养3天,这种巨噬细胞表现出抗炎和促血管生成的特征。我们的数据表明,CX可以将单核细胞培养成一种独特的巨噬细胞群,称为CX教育巨噬细胞(CXMq),分泌高水平的VEGF和IL-6。在体外实验中,CXMq还显示出招募具有已知抗炎特性的间充质间质细胞(MSC)的能力。选择性抑制CXMq上纤维连接蛋白与αVβ3表面整合素的结合可阻止MSC的募集。这表明CX中的不溶性纤维连接蛋白至少部分地负责CXMq转换。
{"title":"Cardiac fibroblast derived matrix-educated macrophages express VEGF and IL-6, and recruit mesenchymal stromal cells","authors":"Sushmita Roy ,&nbsp;Keith Spinali ,&nbsp;Eric G. Schmuck ,&nbsp;John A. Kink ,&nbsp;Peiman Hematti ,&nbsp;Amish N. Raval","doi":"10.1016/j.regen.2020.100033","DOIUrl":"10.1016/j.regen.2020.100033","url":null,"abstract":"<div><p><span>The polarization of monocytes<span> into macrophages that possess anti-inflammatory and pro-angiogenic properties could provide a novel therapeutic strategy for patients who are at a high risk for developing heart failure following myocardial infarction (MI). Here in, we describe a novel method of “educating” monocytes into a distinct population of macrophages that exhibit anti-inflammatory and pro-angiogenic features through a 3-day culture on fibronectin-rich cardiac matrix (CX) manufactured using cultured human cardiac fibroblasts. Our data suggest that CX can educate monocytes into a unique macrophage population termed CX educated macrophages (CXMq) that secrete high levels of VEGF and IL-6. </span></span><em>In vitro</em><span>, CXMq also demonstrate the ability to recruit mesenchymal stromal cells<span><span> (MSC) with known anti-inflammatory properties. Selective inhibition of fibronectin binding to αVβ3 surface </span>integrins on CXMq prevented MSC recruitment. This suggests that insoluble fibronectin within CX is, at least in part, responsible for CXMq conversion.</span></span></p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"10 ","pages":"Article 100033"},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2020.100033","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25354707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Characterizing and overcoming innate immunity in beta-cell replacement therapy 细胞替代疗法中先天免疫的表征和克服
Pub Date : 2020-12-01 DOI: 10.1016/j.regen.2020.100034
Kenjiro Kumano , Srividya Vasu , Rehma Shabbir , Carly Darden , Michael Lawrence , Bashoo Naziruddin

In clinical islet transplantation, the engrafted islet cell mass is a critical factor for maintaining graft function and transplant outcome. This review dissects components that contribute to an acute innate immune response, including ischemia-reperfusion injury, damage-associated molecular patterns, islet-derived cytokines (isletokines), and an instant blood-mediated inflammatory reaction. The cyclical amplification of immune cell response and islet inflammation can occur at each stage of the transplant process. As such, strategies to improve islet transplantation include minimizing islet and immune cell cytokine production prior to procurement; suppressing the pretransplant islet immune inflammatory response; inhibiting the instant blood-mediated inflammatory reaction in the liver; preventing an innate immune response by encapsulation and islet surface modification; targeting cytokine/chemokine secretion and innate immune cell infiltration; considering the optimal site for islet engraftment; blocking cytokine signaling in islets; and implementing anti-inflammatory strategies to improve islet transplantation. A large body of evidence indicates that targeting immune components at multiple steps throughout the transplant procedure can improve overall islet transplant outcomes.

在临床胰岛移植中,移植的胰岛细胞团块是维持移植物功能和移植结果的关键因素。这篇综述剖析了急性先天免疫反应的组成部分,包括缺血再灌注损伤、损伤相关的分子模式、胰岛源性细胞因子(胰岛因子)和即时血液介导的炎症反应。免疫细胞反应和胰岛炎症的周期性扩增可发生在移植过程的每个阶段。因此,改善胰岛移植的策略包括在采购之前尽量减少胰岛和免疫细胞细胞因子的产生;抑制移植前胰岛免疫炎症反应;抑制肝脏即时血液介导的炎症反应;通过包封和胰岛表面修饰预防先天免疫反应靶向细胞因子/趋化因子分泌与先天免疫细胞浸润;考虑胰岛移植的最佳位置;阻断胰岛细胞因子信号传导;实施抗炎策略以改善胰岛移植。大量证据表明,在整个移植过程的多个步骤中靶向免疫成分可以改善整体胰岛移植结果。
{"title":"Characterizing and overcoming innate immunity in beta-cell replacement therapy","authors":"Kenjiro Kumano ,&nbsp;Srividya Vasu ,&nbsp;Rehma Shabbir ,&nbsp;Carly Darden ,&nbsp;Michael Lawrence ,&nbsp;Bashoo Naziruddin","doi":"10.1016/j.regen.2020.100034","DOIUrl":"10.1016/j.regen.2020.100034","url":null,"abstract":"<div><p><span><span>In clinical islet transplantation<span><span><span>, the engrafted islet cell mass is a critical factor for maintaining graft function and transplant outcome. This review dissects components that contribute to an acute innate immune response, including ischemia-reperfusion injury, damage-associated </span>molecular patterns, islet-derived cytokines (isletokines), and an instant blood-mediated inflammatory reaction. The cyclical amplification of </span>immune cell response and islet inflammation can occur at each stage of the transplant process. As such, strategies to improve islet transplantation include minimizing islet and immune cell </span></span>cytokine production<span> prior to procurement; suppressing the pretransplant islet immune inflammatory response; inhibiting the instant blood-mediated inflammatory reaction in the liver; preventing an innate immune response by encapsulation and islet surface modification; targeting cytokine/chemokine secretion and innate immune cell infiltration<span>; considering the optimal site for islet engraftment<span>; blocking cytokine signaling in islets; and implementing anti-inflammatory strategies to improve islet transplantation. A large body of evidence indicates that targeting immune components at multiple steps throughout the </span></span></span></span>transplant procedure can improve overall islet transplant outcomes.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"10 ","pages":"Article 100034"},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2020.100034","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90614956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
An accurate and rapid single step protocol for enumeration of cytokine positive T lymphocytes 一种准确、快速的单步细胞因子阳性T淋巴细胞计数方法
Pub Date : 2020-09-01 DOI: 10.1016/j.regen.2020.100032
Deepa Rajagopal , Linhua Tian , Shiqiu Xiong , Lili Wang , Jonathan Campbell , Luisa Saraiva , Sandrine Vessillier

Accurate determination of cellular subsets that secrete particular cytokine(s) is a significant parameter for functional characterization of an immunological response. The present study was conducted to develop a method for simultaneous measurement of intracellular cytokine positive CD4 and CD8 positive T lymphocytes in a single tube, with a no-wash protocol. We report here the development of a simplified, rapid procedure for precise enumeration of cytokine positive T lymphocytes using BD Trucount tubes. This single step protocol for accurate enumeration of cytokine positive T lymphocytes, will allow for better characterization of immune cell phenotype and function.

准确测定分泌特定细胞因子的细胞亚群是免疫反应功能表征的重要参数。本研究旨在开发一种在单管中同时测量细胞内细胞因子阳性CD4和CD8阳性T淋巴细胞的方法,采用无清洗方案。我们在此报告了一种使用BD Trucount管精确计数细胞因子阳性T淋巴细胞的简化,快速程序的发展。这一单步方案精确枚举细胞因子阳性T淋巴细胞,将允许更好地表征免疫细胞表型和功能。
{"title":"An accurate and rapid single step protocol for enumeration of cytokine positive T lymphocytes","authors":"Deepa Rajagopal ,&nbsp;Linhua Tian ,&nbsp;Shiqiu Xiong ,&nbsp;Lili Wang ,&nbsp;Jonathan Campbell ,&nbsp;Luisa Saraiva ,&nbsp;Sandrine Vessillier","doi":"10.1016/j.regen.2020.100032","DOIUrl":"10.1016/j.regen.2020.100032","url":null,"abstract":"<div><p>Accurate determination of cellular subsets that secrete particular cytokine(s) is a significant parameter for functional characterization of an immunological response. The present study was conducted to develop a method for simultaneous measurement of intracellular cytokine positive CD4 and CD8 positive T lymphocytes in a single tube, with a no-wash protocol. We report here the development of a simplified, rapid procedure for precise enumeration of cytokine positive T lymphocytes using BD Trucount tubes. This single step protocol for accurate enumeration of cytokine positive T lymphocytes, will allow for better characterization of immune cell phenotype and function.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"9 ","pages":"Article 100032"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2020.100032","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39068809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single cell sequencing analysis of lizard phagocytic cell populations and their role in tail regeneration 蜥蜴吞噬细胞群的单细胞测序分析及其在尾巴再生中的作用
Pub Date : 2020-06-01 DOI: 10.1016/j.regen.2020.100029
Ricardo Londono , Sean Tighe , Beatrice Milnes , Christian DeMoya , Lina Maria Quijano , Megan L. Hudnall , Joseph Nguyen , Evelyn Tran , Stephen Badylak , Thomas P. Lozito

Lizards are the closest relatives of mammals capable of tail regeneration, but the specific determinants of amniote regenerative capabilities are currently unknown. Macrophages are phagocytic immune cells that play a critical role in wound healing and tissue regeneration in a wide range of species. We hypothesize that macrophages regulate the process of lizard tail regeneration, and that comparisons with mammalian cell populations will yield insight into the role phagocytes play in determining an organism's regenerative potential. Single cell RNA sequencing (scRNAseq) was used to profile lizard immune cells and compare with mouse counterparts to contrast cell types between the two species. Treatment with clodronate liposomes effectively inhibited lizard tail stump tissue ablation and subsequent regeneration, and scRNAseq was used to profile changes in lizard immune cell populations resulting from tail amputation as well as identifying specific cell types affected by clodronate treatment. ScRNAseq analysis of lizard bone marrow, peripheral blood, and tissue-resident phagocyte cell populations was used to trace marker progression during macrophage differentiation and activation. These results indicated that lizard macrophages are recruited to tail amputation injuries faster than mouse populations and express high levels of matrix metalloproteinases (MMPs). In turn, treatment with MMP inhibitors inhibited lizard tail regeneration. These results provide single cell sequencing data sets for evaluating and comparing lizard and mammalian immune cell populations, and identifying macrophage populations that are critical regulators of lizard tail regrowth.

蜥蜴是能够再生尾巴的哺乳动物的近亲,但羊膜再生能力的具体决定因素目前尚不清楚。巨噬细胞是一种吞噬性免疫细胞,在许多物种的伤口愈合和组织再生中起着关键作用。我们假设巨噬细胞调节蜥蜴尾巴再生的过程,并与哺乳动物细胞群进行比较,将深入了解吞噬细胞在决定生物体再生潜力中的作用。单细胞RNA测序(scRNAseq)用于分析蜥蜴的免疫细胞,并与小鼠的对应细胞进行比较,以对比两种物种之间的细胞类型。氯膦酸脂质体治疗可有效抑制蜥蜴尾残端组织消融和随后的再生,scRNAseq用于分析蜥蜴尾截肢后免疫细胞群的变化,以及鉴定受氯膦酸盐治疗影响的特定细胞类型。利用蜥蜴骨髓、外周血和组织常驻吞噬细胞群的ScRNAseq分析来追踪巨噬细胞分化和激活过程中的标志物进展。这些结果表明,蜥蜴巨噬细胞比小鼠群体更快地被招募到尾巴截肢损伤中,并表达高水平的基质金属蛋白酶(MMPs)。反过来,用MMP抑制剂治疗会抑制蜥蜴尾巴的再生。这些结果提供了单细胞测序数据集,用于评估和比较蜥蜴和哺乳动物的免疫细胞群,并鉴定巨噬细胞群是蜥蜴尾巴再生的关键调节因子。
{"title":"Single cell sequencing analysis of lizard phagocytic cell populations and their role in tail regeneration","authors":"Ricardo Londono ,&nbsp;Sean Tighe ,&nbsp;Beatrice Milnes ,&nbsp;Christian DeMoya ,&nbsp;Lina Maria Quijano ,&nbsp;Megan L. Hudnall ,&nbsp;Joseph Nguyen ,&nbsp;Evelyn Tran ,&nbsp;Stephen Badylak ,&nbsp;Thomas P. Lozito","doi":"10.1016/j.regen.2020.100029","DOIUrl":"10.1016/j.regen.2020.100029","url":null,"abstract":"<div><p>Lizards are the closest relatives of mammals capable of tail regeneration, but the specific determinants of amniote<span><span> regenerative capabilities are currently unknown. Macrophages are phagocytic immune cells<span> that play a critical role in wound healing and tissue regeneration<span> in a wide range of species. We hypothesize that macrophages regulate the process of lizard tail regeneration, and that comparisons with mammalian cell populations will yield insight into the role </span></span></span>phagocytes<span><span><span><span> play in determining an organism's regenerative potential. Single cell RNA sequencing (scRNAseq) was used to profile lizard immune cells and compare with mouse counterparts to contrast cell types between the two species. </span>Treatment with </span>clodronate<span> liposomes<span> effectively inhibited lizard tail stump tissue ablation<span> and subsequent regeneration, and scRNAseq was used to profile changes in lizard immune cell populations resulting from tail amputation as well as identifying specific cell types affected by clodronate treatment. ScRNAseq analysis of lizard bone marrow, peripheral blood, and tissue-resident phagocyte cell populations was used to trace marker progression during macrophage differentiation and activation. These results indicated that lizard macrophages are recruited to tail amputation injuries faster than mouse populations and express high levels of </span></span></span></span>matrix metalloproteinases<span><span> (MMPs). In turn, treatment with MMP inhibitors<span> inhibited lizard tail regeneration. These results provide single cell sequencing data sets for evaluating and comparing lizard and mammalian immune cell populations, and identifying macrophage populations that are critical regulators of lizard tail </span></span>regrowth.</span></span></span></p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"8 ","pages":"Article 100029"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2020.100029","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37874691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Treg regulation of the epithelial stem cell lineage 上皮干细胞谱系的Treg调控
Pub Date : 2020-06-01 DOI: 10.1016/j.regen.2020.100028
Inchul Cho , Prudence Pokwai Lui , Niwa Ali

Tissue repair and maintenance in adult organisms is dependent on the interactions between stem cells (SCs) and constituent cells of their microenvironment, or niche. Accumulating evidence suggests that immune cells, specifically Foxp3+ CD4+ Regulatory T cells (Tregs), play an important role as a regulator of the SC niche. Undisputedly, Tregs are the major immunosuppressive lineage of the CD4+ T cell compartment, and reside within numerous secondary lymphoid organs, where they exert their functions. These cells are also specialised in facilitating protective functions specific to their tissue of residence. In this review, we discuss the emerging concepts supporting the SC-regulatory functions of tissue-resident Tregs, during both the steady-state and SC-mediated regeneration. We highlight the skin, intestines, and lung as model organs which are subject to recurrent microinjury,exposure to microbiota, and constantly replenished by resident stem cell populations. An in-depth understanding of the biology of the Treg-SC axis will inform ongoing immunotherapeutic endeavours to target specific subpopulations of tissue-resident Tregs.

成体生物的组织修复和维持依赖于干细胞(SCs)与其微环境或生态位组成细胞之间的相互作用。越来越多的证据表明,免疫细胞,特别是Foxp3+ CD4+调节性T细胞(Tregs),在SC生态位的调节中起着重要作用。毋庸置疑,treg是CD4+ T细胞室的主要免疫抑制谱系,存在于许多次级淋巴器官中,在那里它们发挥作用。这些细胞还专门用于促进其居住组织特有的保护功能。在这篇综述中,我们讨论了在稳态和sc介导的再生过程中支持组织驻留treg的sc调节功能的新兴概念。我们强调皮肤、肠和肺是受反复微损伤、暴露于微生物群并不断被常驻干细胞群补充的模型器官。深入了解Treg-SC轴的生物学将为正在进行的针对组织驻留treg的特定亚群的免疫治疗工作提供信息。
{"title":"Treg regulation of the epithelial stem cell lineage","authors":"Inchul Cho ,&nbsp;Prudence Pokwai Lui ,&nbsp;Niwa Ali","doi":"10.1016/j.regen.2020.100028","DOIUrl":"10.1016/j.regen.2020.100028","url":null,"abstract":"<div><p>Tissue repair and maintenance in adult organisms is dependent on the interactions between stem cells (SCs) and constituent cells of their microenvironment, or niche. Accumulating evidence suggests that immune cells, specifically Foxp3<sup>+</sup> CD4<sup>+</sup> Regulatory T cells (Tregs), play an important role as a regulator of the SC niche. Undisputedly, Tregs are the major immunosuppressive lineage of the CD4<sup>+</sup> T cell compartment, and reside within numerous secondary lymphoid organs, where they exert their functions. These cells are also specialised in facilitating protective functions specific to their tissue of residence. In this review, we discuss the emerging concepts supporting the SC-regulatory functions of tissue-resident Tregs, during both the steady-state and SC-mediated regeneration. We highlight the skin, intestines, and lung as model organs which are subject to recurrent microinjury,exposure to microbiota, and constantly replenished by resident stem cell populations. An in-depth understanding of the biology of the Treg-SC axis will inform ongoing immunotherapeutic endeavours to target specific subpopulations of tissue-resident Tregs.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"8 ","pages":"Article 100028"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2020.100028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9841168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Decellularized Porcine Achilles Tendon Induces Anti-inflammatory Macrophage Phenotype In Vitro and Tendon Repair In Vivo 脱细胞猪跟腱诱导体外抗炎巨噬细胞表型及体内跟腱修复
Pub Date : 2020-06-01 DOI: 10.1016/j.regen.2020.100027
Aysegul Dede Eren , Ravi Sinha , Egemen Deniz Eren , Yuan Huipin , Sultan Gulce-Iz , Henriette Valster , Lorenzo Moroni , Jasper Foolen , Jan de Boer

Decellularized tissues and organs from animal sources are widely used in regenerative medicine and tissue engineering. However, in tendon tissue engineering there is limitation not only in terms of tissue source -allografts and autografts- but also standardization of decellularization techniques. The goal of this study is to decellularize porcine Achilles tendon to be used as an off-the-shelf product for tendon reconstruction. We describe a novel, mild decellularization strategy which retains the biochemical and biomechanical characteristics of native tendon upon decellularization. We further show that decellularized tendon sections in vitro induce tenogenic differentiation in stem cells and anti-inflammatory response in naïve macrophages. Upon implantation in an Achilles tendon defectin rabbits, we observed that decellularized tendons integrated with the host tissue without signs of tissue rejection or encapsulation. Together, we demonstrate that decellularized tendons produced with our new protocol bear a great potential for tendon tissue regeneration.

动物脱细胞组织和器官在再生医学和组织工程中有着广泛的应用。然而,在肌腱组织工程中,不仅组织来源(同种异体移植物和自体移植物)存在限制,而且脱细胞技术的标准化也存在限制。本研究的目的是使猪跟腱脱细胞,作为一种现成的产品用于跟腱重建。我们描述了一种新的,温和的脱细胞策略,在脱细胞时保留了天然肌腱的生化和生物力学特征。我们进一步表明,体外脱细胞肌腱切片诱导干细胞的成肌腱分化和naïve巨噬细胞的抗炎反应。在植入跟腱缺损兔后,我们观察到脱细胞肌腱与宿主组织融合,没有组织排斥或包封的迹象。总之,我们证明了用我们的新方案产生的脱细胞肌腱具有肌腱组织再生的巨大潜力。
{"title":"Decellularized Porcine Achilles Tendon Induces Anti-inflammatory Macrophage Phenotype In Vitro and Tendon Repair In Vivo","authors":"Aysegul Dede Eren ,&nbsp;Ravi Sinha ,&nbsp;Egemen Deniz Eren ,&nbsp;Yuan Huipin ,&nbsp;Sultan Gulce-Iz ,&nbsp;Henriette Valster ,&nbsp;Lorenzo Moroni ,&nbsp;Jasper Foolen ,&nbsp;Jan de Boer","doi":"10.1016/j.regen.2020.100027","DOIUrl":"10.1016/j.regen.2020.100027","url":null,"abstract":"<div><p>Decellularized tissues and organs from animal sources are widely used in regenerative medicine and tissue engineering. However, in tendon tissue engineering there is limitation not only in terms of tissue source -allografts and autografts- but also standardization of decellularization techniques. The goal of this study is to decellularize porcine Achilles tendon to be used as an off-the-shelf product for tendon reconstruction. We describe a novel, mild decellularization strategy which retains the biochemical and biomechanical characteristics of native tendon upon decellularization. We further show that decellularized tendon sections <em>in vitro</em> induce tenogenic differentiation in stem cells and anti-inflammatory response in naïve macrophages. Upon implantation in an Achilles tendon defectin rabbits, we observed that decellularized tendons integrated with the host tissue without signs of tissue rejection or encapsulation. Together, we demonstrate that decellularized tendons produced with our new protocol bear a great potential for tendon tissue regeneration.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"8 ","pages":"Article 100027"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2020.100027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84886922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
期刊
Journal of immunology and regenerative medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1